Genetic heterogeneity of hepatitis C virus cell entry receptors seems to have no influence on selection of virus variants
© Lipskoch et al.; licensee BioMed Central Ltd. 2014
Received: 7 November 2013
Accepted: 3 March 2014
Published: 14 March 2014
No information is available on the possible influence of the genetic heterogeneity of major hepatitis C virus (HCV) cell receptors on selection of virus variants.
Anti-D globulin preparations contaminated with the HCV strain AD78 caused hepatitis C infection in more than 3000 women in East Germany in 1978. Analysis of the core to NS2 gene sequences of this strain in several globulin batches revealed the presence of three closely related but distinct virus variants of the same strain. Apparently even distribution of these three virus variants was observed in 91 patients infected with the AD78 strain. None of these patients was infected with more than one virus variant, suggesting a selection mechanism of a particular virus variant in each patient. To verify the hypothesis that heterogeneity of HCV cell receptors might influence the virus variant selection, single-nucleotide polymorphisms (SNPs) in low-density lipoprotein receptor (LDLR), occludin (OCLN), and scavenger receptor B1 (SCARB1) genes in AD patients were analyzed. No evident correlation between receptor polymorphisms and presence of a particular virus variant was noted.
SNPs of HCV cell entry receptors have no influence on virus selection in patients infected with an inoculum containing different virus variants.
KeywordsHCV AD78 HCV cell receptor polymorphism LDLR OCLN SCARB1
Accumulating data show that mixed infection with two or several HCV genotypes or subtypes usually is a very low event even among multiple exposed individuals such as intravenous drug users . These data suggest the existence of mechanism(s) that restricts either the coinfection of hepatocytes with two or several virus variants or superinfection or both. Recently, a phenomenon of HCV superinfection exclusion by already infected Huh7 hepatoma cells due to interference at the level of HCV RNA translation and/or replication has been described [2, 3]. Such a restriction may also function at other stages of the HCV replicative cycle, including the entry step. Thus, the Huh7 cells infected with one HCV strain demonstrate downregulation of expression of two key factors for HCV entry – claudine-1 and occludin .
The SNPs in the major HCV cell receptor genes chosen for analysis
Genomic DNA isolated from EDTA-blood of AD78-infected patients was used for detection of SNPs by real-time PCR (LightSNiP Assay). This test is based on melting curve analysis and allows for detection of mutations located within the sequence segment corresponding to a hybridization probe.
One should note, however, that in the current study heterogeneity of only the major HCV receptor LDLR, SCARB1, and OCLN genes was investigated. In the last few years a number of additional cell factors and co-factors facilitating the HCV entry process have been described [8–10]. These factors include epidermal growth factor receptor (EGFR), ephrin receptor A2 (EphA2), Niemann-Pick C1-Like 1 cholesterol absorption receptor (NPC1L1), and transferrin receptor 1 (TFR1). However, information on the genetic heterogeneity of these proteins at the moment is scarce. That precludes a detailed analysis of a contribution of polymorphism of newly identified HCV entry factors to virus variant selection in case of a complex HCV inoculum.
The fact that anti-D patients did not harbor more than one virus variant might not be attributed only to the HCV receptor heterogeneity. One recent comprehensive study has demonstrated that even minor differences in E1/E2 sequence can result in marked changes of viral fitness . The authors have shown that upon HCV inoculation of SCID/Alb-uPA mice with transplanted human hepatocytes the resulting infections were caused not by virus variants predominant in the inoculum but by variants, which were present there only in minute amounts. One might suggest that in our anti-D cohort the selection of HCV AD78 variants could also be determined on the one hand by differences in their fitness and on the other hand by host genetic factors other than HCV receptors and entry co-factors. It would be of great interest to apply the human liver cells graft-mouse system for studies of infectivity of the HCV AD78 variants present in contaminated anti-D globulin batches and in sera from individual anti-D patients.
Material and methods
A large HCV genotype 1b single source outbreak after immunization of about 3000 women with virus contaminated anti-D immunoglobulin occurred in East Germany in 1978–1979 . Samples from this anti-D cohort were collected since 2008 by members of the East German HCV study group . The HCV RNA–positive samples from 91 of these patients were randomly selected  and included in this study.
DNA amplification and sequencing
Viral RNA from serum samples of 91 infected patients was extracted using the RNeasy kit (Qiagen) and reverse transcribed into cDNA using the Thermoscript kit (Invitrogen) according to manufacture’s instructions. The HCV core-NS2 genomic region (codons 342 to 3419, according to the AF009606 HCV isolate) was amplified in four overlapping fragments by standard PCR techniques. A list of primers is provided as Additional file 1: Table S1. The DNA fragments were gel-purified using the QIAquick Gel Extraction Kit (Qiagen) and cloned into the pCR4-TOPO plasmid (Invitrogen). Sequencing of DNA fragments was outsourced to LGC Genomics in Berlin, Germany. Direct or clonal sequences were subjected to phylogenetic analysis using the Phylip-package (version 3.69) and statistical confidence was estimated from 100 bootstrapped trees.
Genomic DNA isolated from EDTA-blood of 91 AD78-infected patients was used for detection of SNPs of the HCV cell receptor genes LDLR, SCARB1, and OCLN by LightSNiP Assay (TibMolbiol) according the manufacturer’s instructions using the LightCycler 2.
We thank the East German Study Group e.V. for contributing samples of the East German Anti-D cohort. The authors thank Mrs. Sina Luppus for her excellent technical assistance. This work was supported by grant from the German Federal Ministry of Education and Health (BMBF).
- Viazov S, Ross SS, Kyuregyan KK, Timm J, Neumann-Haefelin C, Isaeva OV, Popova OE, Dmitriev PN, El Sharkawi F, Thimme R, Michailov MI, Roggendorf M: Hepatitis C virus recombinants are rare even among intravenous drug users. J Med Virol 2010, 82:232–238. 10.1002/jmv.21631View ArticlePubMed
- Schaller T, Appel N, Koutsoudakis G, Kallis S, Lohmann V, Pietschmann T, Bartenschlager R: Analysis of hepatitis C virus superinfection exclusion by using novel fluorochrome gene-tagged viral genomes. J Virol 2007, 81:4591–4603. 10.1128/JVI.02144-06View ArticlePubMed CentralPubMed
- Tscherne DM, Evans MJ, van Hahn T, Jones CT, Stamataki Z, McKeating JA, Lindenbach BD, Rice CM: Superinfection exclusion in cells infected with hepatitis C virus. J Virol 2007, 81:3693–3703. 10.1128/JVI.01748-06View ArticlePubMed CentralPubMed
- Liu S, Yang W, Shen L, Turner JR, Coyne CB, Wang T: Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection. J Virol 2009, 83:2011–2014. 10.1128/JVI.01888-08View ArticlePubMed CentralPubMed
- Wiese M, Fischer J, Löbermann M, Göbel U, Grüngreiff K, Güthoff W, Kullig U, Richter F, Schiefke I, Tenckhoff H, Zipprich A, Berg T, Müller T, for the East German HCV Study Group: Evaluation of liver disease progression in the German HCV (1b)-contaminated anti-D cohort at 35 years after infection. Hepatology 2014, 59:49–57. 10.1002/hep.26644View ArticlePubMed
- Ruhl M, Knuschke T, Schewior K, Glavinic L, Neumann-Haefelin C, Chang DI, Klein M, Heinemann FM, Tenckhoff H, Wiese M, Horn PA, Viazov S, Spengler U, Roggendorf M, Scherbaum N, Nattermann J, Hoffmann D, Timm J, East German HCV Study Group: CD8+ T-cell response promotes evolution of hepatitis C virus nonstructural proteins. Gastroenterology 2011, 140:2064–2073. 10.1053/j.gastro.2011.02.060View ArticlePubMed
- Ploss A, Evans J: Hepatitis C virus host cell entry. Curr Opin Virol 2012, 2:14–19. 10.1016/j.coviro.2011.12.007View ArticlePubMed CentralPubMed
- Zeisel MB, Felmlee DJ, Baumert TF: Hepatitis C virus entry. Curr Top Microbiol Immuno 2013, 369:87–112.
- Kim CW, Chang K-M: Hepatitis C virus: virology and life cycle. Clin Mol Hepatol 2013, 19:17–25. 10.3350/cmh.2013.19.1.17View ArticlePubMed CentralPubMed
- Martin DN, Uprichard SL: Identification of transferrin receptor 1 as a hepatitis C virus entry factor. Proc Natl Acad Sci USA 2013, 110:10777–10782. 10.1073/pnas.1301764110View ArticlePubMed CentralPubMed
- Brown RJ, Hudson N, Wilson G, Rehman SU, Jabbari S, Hu K, Tarr AW, Borrow P, Joyce M, Lewis J, Zhu LF, Law M, Kneteman N, Tyrrell DL, McKeating JA, Ball JK: Hepatitis C virus envelope glycoprotein fitness defines virus population composition following transmission to a new host. J Virol 2012, 86:11956–11966. 10.1128/JVI.01079-12View ArticlePubMed CentralPubMed
- Tillmann HL, Thompson AJ, Patel K, Wiese M, Tenckhoff H, Nischalke HD, Lokhnygina Y, Kullig U, Göbel U, Capka E, Wiegand J, Schiefke I, Güthoff W, Grüngreiff K, König I, Spengler U, McCarthy J, Shianna KV, Goldstein DB, McHutchison JG, Timm J, Nattermann J, German Anti-D Study Group: A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice. Gastroenterology 2010, 139:1586–1592. 10.1053/j.gastro.2010.07.005View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.